The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Do Women Receive Worse Gout Treatment Than Men?

Do Women Receive Worse Gout Treatment Than Men?

February 5, 2014 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A poster presented at the 2013 ACR/ARHP Annual Meeting in San Diego that examined differences between women and men with gout found women were more likely to have contraindications to nonsteroidal antiinflammatory drugs (NSAIDs), probably due to a higher prevalence of kidney disease. In addition, among patients who were candidates for urate-lowering drugs (ULDs), women were less likely to receive them then men.

You Might Also Like
  • Women Diagnosed Years Later than Men for Same Diseases
  • Hip Bone Deterioration May Differ Significantly Between Men & Women
  • Women Lag Men as Lead Authors in Top Medical Journals
Also By This Author
  • Data Show Outreach Is Working, But Does Rheumatology Have Enough Positions Available?

The lead author on the study, “Sex Differences in Gout Evaluation and Management,” (Abstract #1195) says she hopes the data highlight that rheumatologists and others must work diligently to make sure that women receive optimal gout care.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“While we physicians and rheumatologists think we treat everyone the same and do everything we’re supposed to do, we need to explore if that’s truly the case,” says Leslie Harrold, MD, MPH, associate professor of orthopedics and medicine at the University of Massachusetts Medical School in Worcester. “The treatment differences are not necessarily due to poor care by providers … this is a preliminary study and we need to explore these results using a larger population.”

The report found that while women had similar clinical features in terms of acute gout presentation and gouty arthritis, they were more likely to have contraindications to treatment with NSAIDs (32% vs. 21%, p=0.02) or colchicine (14% vs. 6%, p=0.01). Among those patients with two or more attacks per year or those with tophi, women were also less likely to be on a ULD as compared to men (78% vs. 89%, p=0.02) in both unadjusted and adjusted (OR 0.42, 95% CI 0.19–0.92) analyses.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Harrold’s work was based on initial data from the Consortium of Rheumatology Researchers of North America (CORRONA). As the database offers more information, Dr. Harrold and colleagues plan to continue their analysis. For example, they’ve yet to tease out why the differences in care for men and women exist.

“For crystal-proven gout, we don’t know if the provider offered an aspiration to the patient and more women declined than men,” Dr. Harrold notes. “Same thing with medications. Were they offered the same medications, and women were more likely to decline them than men?

“We don’t know that, but once again, if you don’t identify problems, you can’t solve them.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Richard Quinn is a freelance writer in New Jersey.

Filed Under: Conditions, Crystal Arthritis, Meeting Reports Tagged With: Gout, NSAIDs, Sex Differences

You Might Also Like:
  • Women Diagnosed Years Later than Men for Same Diseases
  • Hip Bone Deterioration May Differ Significantly Between Men & Women
  • Women Lag Men as Lead Authors in Top Medical Journals
  • Women Internists Make 80 Cents for Every Dollar Earned by Men

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)